Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Churg-Strauss syndrome.

Karina A Keogh1, Ulrich Specks

  • 1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

Seminars in Respiratory and Critical Care Medicine
|April 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patients' perspectives of eosinophilic granulomatosis with polyangiitis within the context of a clinical trial.

EULAR rheumatology open·2026
Same author

Therapeutic Dilemmas in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Diffuse Alveolar Hemorrhage and Venous Thromboembolism.

ACR open rheumatology·2026
Same author

Pulmonary manifestations of granulomatosis with polyangiitis and microscopic polyangiitis.

Seminars in arthritis and rheumatism·2026
Same author

Risk Factors for Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Among Patients With Relapse After Induction of Remission With Rituximab.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitis.

Nature reviews. Rheumatology·2025
Same author

Eosinophil-associated disease after SARS-CoV-2 infection or vaccination: EGPA and related entities.

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2025

Churg-Strauss syndrome, a rare vasculitis often linked to asthma treatments, presents with eosinophilic inflammation and vasculitis. Early identification and glucocorticoid treatment are key, though further research on advanced therapies is needed.

Area of Science:

  • Rheumatology
  • Pulmonology
  • Immunology

Background:

  • Churg-Strauss syndrome (CSS), previously allergic granulomatosis and angiitis, is a small-vessel vasculitis.
  • It is characterized by eosinophilic inflammation, granulomas, and necrotizing vasculitis, often in patients with severe asthma.
  • CSS is classified alongside Wegener's granulomatosis and microscopic polyangiitis as an antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis.

Purpose of the Study:

  • To review the classification, presentation, and management of Churg-Strauss syndrome.
  • To highlight the potential unmasking of CSS by glucocorticoid-sparing asthma medications.
  • To discuss diagnostic considerations and current treatment strategies for CSS.

Main Methods:

  • Literature review of Churg-Strauss syndrome.

Related Experiment Videos

  • Analysis of classification and association with ANCA.
  • Summary of clinical presentation and diagnostic challenges.
  • Overview of current treatment approaches, including glucocorticoids and ANCA-associated vasculitis principles.

    • Main Results:

    • ANCA are present in 40-75% of active CSS cases, often targeting myeloperoxidase.
    • Symptoms vary widely, affecting multiple organs due to eosinophilic inflammation and vasculitis.
    • Differential diagnosis includes other eosinophilic lung diseases and ANCA-associated vasculitides.

    Conclusions:

    • Churg-Strauss syndrome is a rare condition with incompletely understood pathogenesis.
    • Primary treatment involves glucocorticoids.
    • Management for ANCA-positive patients follows ANCA-associated vasculitis guidelines, but optimal use of steroid-sparing agents and refractory disease treatments require further study.